By Frank Prenesti
Date: Tuesday 14 Jul 2026
(Sharecast News) - Animal genetics company Genus on Tuesday said it expected annual earnings to be moderately above expectations after a strong second half in Asia and Latin America that more than offset weaker conditions in North America, sending shares in the firm 5% higher.
By Iain Gilbert
Date: Tuesday 14 Jul 2026
(Sharecast News) - Analysts at Berenberg maintained their 'buy' rating on Genus on Tuesday as it said the animal genetics firm's latest trading update showed strong momentum across the business, prompting another upgrade to full‑year guidance and extending what the broker described as a sustained run of improvements since early 2025.
By Iain Gilbert
Date: Monday 29 Jun 2026
(Sharecast News) - Genus revealed on Monday that non-executive director Celia Baxter had acquired 2,336 ordinary shares in the FTSE 250-listed biotech firm.
| Currency | UK Pounds |
| Share Price | 2,256.00p |
| Change Today | 2.00p |
| % Change | 0.09 % |
| 52 Week High | 3,170.00 |
| 52 Week Low | 1,966.00 |
| Volume | 62,243 |
| Shares Issued | 66.54m |
| Market Cap | £1,501.16m |
| Beta | 0.01 |
| RiskGrade | 128 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 05-Mar-26 | 06-Nov-25 |
| Paid | 27-Mar-26 | 05-Dec-25 |
| Amount | 11.20p | 21.70p |
| Time | Volume / Share Price |
| 16:35 | 267 @ 2,256.00p |
| 16:35 | 6 @ 2,256.00p |
| 16:35 | 48,430 @ 2,256.00p |
| 16:35 | 1 @ 2,256.00p |
| 16:35 | 60 @ 2,256.00p |
You are here: research